These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 30194081

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. TP53 Arg 72Pro and MDM2 SNP309 polymorphisms and colorectal cancer risk: a west Algerian population study.
    Abderrahmane R, Louhibi L, Moghtit FZ, Boubekeur A, Benseddik K, Boudjema A, Benrrahal F, Aberkane M, Fodil M, Saidi-Mehtar N.
    Pathol Oncol Res; 2015 Jul; 21(3):629-35. PubMed ID: 25537146
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. MDM2 SNP309 polymorphism as risk factor for susceptibility and poor prognosis in renal cell carcinoma.
    Hirata H, Hinoda Y, Kikuno N, Kawamoto K, Suehiro Y, Tanaka Y, Dahiya R.
    Clin Cancer Res; 2007 Jul 15; 13(14):4123-9. PubMed ID: 17634539
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Association of Murine Double Minute 2 Genotypes and Lung Cancer Risk.
    Lin YC, Chang WS, Shen TC, Li HT, Li CH, Hsiau YC, Wang YC, Wu CN, Gong CL, Wang ZH, Tsai CW, Hsia TC, Bau DT.
    In Vivo; 2020 Jul 15; 34(3):1047-1052. PubMed ID: 32354891
    [Abstract] [Full Text] [Related]

  • 12. Results based on 124 cases of breast cancer and 97 controls from Taiwan suggest that the single nucleotide polymorphism (SNP309) in the MDM2 gene promoter is associated with earlier onset and increased risk of breast cancer.
    Sun YF, Leu JD, Chen SM, Lin IF, Lee YJ.
    BMC Cancer; 2009 Jan 13; 9():13. PubMed ID: 19144119
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. MDM2 promoter polymorphism is associated with increased susceptibility to hepatocellular carcinoma in Turkish population.
    Akkiz H, Sümbül AT, Bayram S, Bekar A, Akgöllü E.
    Cancer Epidemiol; 2010 Aug 13; 34(4):448-52. PubMed ID: 20447891
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Involvement of p53 R72P polymorphism in the association of MDM2-SNP309 with breast cancer.
    Leu JD, Wang CY, Tsai HY, Lin IF, Chen RC, Lee YJ.
    Oncol Rep; 2011 Jun 13; 25(6):1755-63. PubMed ID: 21479369
    [Abstract] [Full Text] [Related]

  • 17. Current evidence on the relationship between SNP309 polymorphism in the MDM2 gene and colorectal cancer risk.
    Fu Q, Zhang G, Chen H, Zheng Y, Cheng J.
    Tumour Biol; 2013 Dec 13; 34(6):3721-9. PubMed ID: 23912932
    [Abstract] [Full Text] [Related]

  • 18. MDM2 SNP309 T>G alone or in combination with the TP53 R72P polymorphism does not appear to influence disease expression and age of diagnosis of colorectal cancer in HNPCC patients.
    Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ.
    Int J Cancer; 2007 Feb 01; 120(3):563-5. PubMed ID: 17096342
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancer.
    Hitzenbichler F, Stoehr CG, Rogenhofer M, Wieland WF, Ruemmele P, Hartmann A, Stoehr R.
    Pathobiology; 2014 Feb 01; 81(2):53-9. PubMed ID: 24217660
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.